4340 Duncan Avenue St. Louis, MO 63110 314-615-6355 info@biogenerator.org

BioGenerator Wins Federal Grant to Build New St. Louis Bioscience Companies

Sep 26, 2017

ST. LOUIS – BioGenerator, the investment arm of BioSTL, has won a $300,000 grant from the U.S. Department of Commerce to capitalize on its retooled investment strategy. That strategy is focused around quickly scaling companies to attract downstream investors, while also building new companies with a faster timeline to sales of commercial products or services.

To date, BioGenerator has invested $17.9 million into 71 companies. These investments attracted more than $530 million in additional capital from outside funders. BioGenerator’s ability to generate that 30x leverage places it among the leading early-stage investors in the country.

Read the Full Press Release Here